Skip to content Skip to footer

Research summary · · 4 min read

In short

  • Researchers re-analysed brain scans of healthy volunteers given LSD, psilocybin, mescaline, MDMA, amphetamine or a placebo.
  • The classic psychedelics increased the number of “gateway” regions that gather information into the brain’s global workspace, especially in networks for flexible thinking and attention.
  • The more alike two substances’ brain changes were, the more alike people’s experiences were.

What the researchers did

One leading theory of consciousness, the global workspace theory, describes the brain as a theatre: information becomes conscious when it reaches a shared stage and is broadcast widely. Some regions act as gateways that gather information onto the stage, others as broadcasters that send it out. The researchers mapped this workspace in 100 healthy people and then applied the map to brain scans from two placebo-controlled studies in Basel.

What they found

LSD, psilocybin and mescaline all increased the number of gateway regions in the networks that handle flexible control and attention, by about four regions on average, while reducing them in some sensory and emotional areas. MDMA and amphetamine changed the workspace in different ways. Across all the substances, the more similar the brain changes, the more similar the experiences people reported.

Why it matters

People often describe psychedelic states as “more”: more open, more connected, as if everything mattered at once. This study suggests that it is not simply a matter of the whole brain becoming more connected, but of the stage itself being rearranged, with more of the brain’s higher systems gathering what comes in. It is a fascinating picture of how the ordinary boundaries of experience might widen. Brain maps describe; they do not tell us what an experience means. That part stays with the person, and with the work of integration.

Keep in mind

This is a preprint re-analysing resting-state scans from small groups of healthy volunteers, and the gateway measure comes from a computational model. The results need confirming in independent studies.

Experience it for yourself

Our small-group retreats combine careful preparation, ceremonies and integration, led by psychologists and psychotherapists.

See our retreats

This summary is for information only and is not medical advice. Psychedelics are controlled substances in many countries, including the UK.

You may also like

All articles

Dr Christoph Zwolan

Dr Christoph ZwolanChristoph is a psychologist and the founder of Numinous Ways. His work focuses on transpersonal psychology, mystical experience and the integration of psychedelic experiences. More about Christoph

Find Us

3 Hill Street, New Town
Edinburgh, EH2 3JP

More Info
Subscribe to Our Newsletter

Numinous Ways © 2026. All Rights Reserved.